Dimension Inx has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Dimension Inx is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Caralynn Collens played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Dimension Inx
Dimension Inx is a biomaterials platform. We design and develop therapeutic products that restore tissue and organ function. We work shoulder-to-shoulder with biotech and medical device partners to help solve their most challenging materials problems. Give the body a blueprint to heal itself. We design and develop therapeutic products that restore tissue and organ function. Our biomaterials and manufacturing process enable unparalleled design versatility and a nuanced microarchitecture that drives biofunctionality.
To learn more about Dimension Inx, visit http://www.dimensioninx.com/
Contact:
Caralynn Collens, President and Chief Executive Officer
312-235-3510
https://www.linkedin.com/in/caralynnnowinski/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.